According to the Russian Direct Investment Fund (RDIF), the Russian Sputnik V and Sputnik Light vaccines have proven to be highly effective against all variants of SARC-Cov-2
Growing CRISPR genome editing portfolio supports researchers on path to future therapeutic applications
The company has has 10 existing labs in India
Market demand for significant volumes and quality of biopharma products would drive continuous manufacturing technologies
The company is marketing the kit under the brand name CoviFind and it can detect the infection in 15 minutes
A first for the Asian market, addressing the health spends needs of over 200 million households.
One-shot Sputnik Light is a highly effective vaccine when used both on standalone basis and applied as a booster
The companies expect to manufacture over 80 million does of the Covid-19 vaccine in 2022
The Indian medical devices industry has been in focus since the pandemic. From US $ 11 billion in 2020 it is expected to touch US $ 50 billion by 2025. Mehernosh Daruwalla, Founder and MD, Lotus Surgicals shares a perspective with Thomas C Thottathil on the opportunities in this sector
Featuring identity verification using artificial intelligence (AI), LabPort was designed to facilitate immediate results reporting for diagnostic testing even in high-volume, field-based testing environments
Subscribe To Our Newsletter & Stay Updated
